Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Sama Therapeutics and Quine Biologics Announce Collaboration to Develop Breakthrough Antibody Therapeutics for Neurological Disorders
Sama Therapeutics and Quine Biologics have partnered to develop an innovative therapy for neurological disorders, combining AI-driven platforms and advanced antibody engineering. The collaboration focuses on biologics that precisely target the central nervous system, minimizing side effects. By integrating Sama's generative AI with Quine's antibody design expertise, the project addresses unmet medical needs and advances treatments for conditions like Alzheimer’s and multiple sclerosis. - September 13, 2024 - Quine Biologics, Inc.
Huntington Study Group and HD Genetics Collaborate to Better Serve HD Gene Positive Patients
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce a strategic partnership with HD Genetics to assist patients who have tested positive for Huntington’s disease (HD) learn about and enroll in research studies. There remains a... - September 05, 2024 - Huntington Study Group
Precision Medicine Hero Partners with MedTrait® and Dynamic DNA Laboratories to Deliver Pharmacy-Forward PGx Solutions to the Precision Medicine Provider Community
Precision Medicine Hero (PMH) announces a preferred partnership with pharmacist-forward precision medicine reporting platform MedTrait®, and pharmacogenetic (PGx) testing laboratory Dynamic DNA Labs, to facilitate their members’ access to advanced solutions for comprehensive PGx-guided medication management. - September 05, 2024 - Precision Medicine Hero
Ember Group Consulting Launches, Offering Transformative Solutions for Businesses
Ember Group Consulting LLC, a new global consulting firm specializing in organizational transformation and adaptive workforce solutions, officially launched today. The firm partners with visionary leaders to drive sustainable change and empower teams for peak performance. Leading Ember Group... - September 04, 2024 - Ember Group Consulting LLC
ALS Therapy Development Institute Commemorates 25th Anniversary at the Leadership Weekend in October
Taking place from October 3-5, 2024, in the Boston area, ALS TDI’s Leadership Weekend features a series of community-focused events, including an Open House at ALS TDI’s cutting-edge research lab, the ALS TDI Research Summit, and the White Coat Affair gala. - September 03, 2024 - ALS Therapy Development Institute
Huntington Study Group Announces New CEO
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive... - August 20, 2024 - Huntington Study Group
Chartwell Launches New Ambulatory Infusion Suite in Oakdale, PA
Chartwell Pennsylvania, LP is proud to announce the launch of a new, nine-chair infusion suite, located in our Oakdale, PA headquarters. CHOICE by Chartwell provides a new alternative for patients to choose where they would like to receive their infusion therapy: at home, or at the new infusion Suite, located just minutes from Robinson Township and Pittsburgh, PA. The suite provides additional options for patients beyond physician offices or at their local hospital. - August 16, 2024 - Chartwell Pennslyvania, LP
Californians Reject Board of Pharmacy’s Proposed Restrictions on Essential Alternative Medicines
Californians fight back against the Board of Pharmacy's proposed regulations that would severely restrict – and in many cases end – access to widely used sterile compounds like methylcobalamin (vitamin B12), glutathione, and NAD, easily accessible and legal in all 49 other United States. The Stop The BOP movement was formed in response, rallying significant public support to preserve access to these essential treatments. - August 08, 2024 - Stop The BOP
Parvus Therapeutics Announces Leadership Appointments to Support Development from Preclinical Into Clinical
New Positions Enhance Parvus Capability to Execute the Translation of Multiple Drug Candidates into the Clinic. - August 06, 2024 - Parvus Therapeutics U.S., Inc.
PARIS Technologies International, Inc. Partners with Nordica Software Distributor to Deliver Retail Industry Analytics and Cash Flow Solutions
PARIS Technologies International, Inc., developer of a software suite for collaborative FP&A and other performance management solutions, has launched a distributor partnership with Nordica, a highly respected data consulting and analytics firm with business extending throughout Brazil and Latin... - August 03, 2024 - PARIS Technologies, Inc.
GENINVO, a Leading Provider of Innovations in Life Science Announced the Offering of Its On-Demand Service/Tool: DocQC
GENINVO has been working towards automating healthcare industry and contributing to faster drug discovery. GENINVO target to bring innovations as technologies, to automate the traditional and time-consuming process of Medical Writing. One example being, automating the process of clinical and... - August 02, 2024 - GenInvo, Inc.
Parvus Therapeutics Has Received Orphan Drug Designation for Primary Biliary Cholangitis and Human Research Ethics Committee Approval to Begin Clinical Testing
Parvus Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to PVT201 for the treatment of Primary Biliary Cholangitis (PBC) and PVT201 has obtained Australian Human Research Ethics Committee (HREC) approval to initiate a first-in-human... - July 29, 2024 - Parvus Therapeutics U.S., Inc.
U.S. Precision Medicine, Inc. Signs MOU to Deploy microNeb’s VIGIL Series Inhaler Technology to Enhance Absorption of Its New Drug Candidate in IND Process
U.S. Precision Medicine, Inc. (USPM) has signed a Memorandum of Understanding (MOU) to deploy microNeb's advanced inhaler technology to expedite the uptake of its new cancer drug candidate currently in the Investigational New Drug (IND) process. - July 16, 2024 - microNeb, Inc.
Nuvem, a Leading Pharmacy Technology and Services Company Appoints New CTO
Nuvem, a high-growth, healthcare technology company offering an integrated suite of pharmacy claims administration technology, high-level of 340B support and services and onsite pharmacy management services to safety net healthcare providers, announced that Jim Harter has joined the Company as its... - July 16, 2024 - Nuvem
MC4R Agonist Drug Candidates Demonstrate Potential to Transform GLP1 Obesity Therapy
Courage Therapeutics announced new evidence of synergy between MC4R agonists and GLP1RA drugs in a paper published in the Journal of Clinical Investigation led by co-founder Dr. Roger Cone. The company has completed a drug discovery campaign to invent a best in class portfolio of MC4R agonists for obesity in order to leverage the synergy. Potential combinations with drugs such as Ozempic and Mounjaro could improve side effects such as nausea and GI discomfort while driving increased weight loss. - July 16, 2024 - Courage Therapeutics
I Holland Launches Tooling Safe Disposal & Recycling Service
I Holland, has launched its new Safe Disposal &Recycling Service. This valuable service is designed to ensure the safe, secure, and environmentally responsible destruction of obsolete or worn-out tooling, enhancing both the integrity and sustainability of pharmaceutical manufacturing. Their... - June 23, 2024 - I Holland Ltd.
Megalabs Acquires Majority Interest and Control of DS Laboratories
Megalabs, a leading pharmaceutical company, has acquired majority interest and control of DS Laboratories (“DS Labs”), a leading dermatology company focused on science backed hair care across 50+ countries. This strategic move enhances Megalabs' position in the global dermatology market and the US. - May 31, 2024 - Megalabs
Sosemo LLC Awarded on the Financial Times Americas’ Fastest Growing Companies 2024 List
Sosemo LLC Awarded on the Financial Times Americas’ Fastest Growing Companies 2024 List Sosemo LLC has been awarded on the Financial Times list of The Americas’ Fastest Growing Companies 2024. This prestigious award is presented by the Financial Times and Statista Inc., the... - May 30, 2024 - Sosemo
Suabix™ Now Live; Revolutionizing Healthcare with Cutting-Edge AI Human Factors Copilot and Consulting Services for Product Development Teams
Suabix™ by Successful Human Factors™, is the first AI Human Factors Copilot for medical product teams, revolutionizing the future of healthcare and patient safety. Successful Human Factors™ is also offering AI integration services tailored to stakeholders needs, powered by Suabix. - May 21, 2024 - Successful Human Factors™
GENINVO Launches Its Latest Offering – DocWrightAI
GENINVO, a leading provider of life science products and business solutions announced the launch of its new, on-demand service: DocWrightAI. GENINVO understands the various challenges in generating clinical documents. The time taken to draft clinical documents with accuracy and compliance has... - May 18, 2024 - GenInvo, Inc.
Novugen Launches Pazopanib Tablets, 200mg, in the U.S. Following ANDA Approval by USFDA
Novugen has launched Pazopanib tablets, 200mg, in the U.S. after receiving ANDA approval from USFDA on April 23, 2024. This significant milestone demonstrates Novugen's continued growth in the U.S. pharmaceutical market with a complex anticancer drug, the generic equivalent of Votrient, used to treat advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS). - May 07, 2024 - Novugen
Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease
AnzuBridge® updates its CDMS to enhance biotech evaluations with advanced video tools, ensuring precise efficacy recording and compliance. It supports scalable trials and features HIPAA-compliant media capture, ePRO for patient engagement, and sophisticated video review capabilities, all integrated with a Learning Management System for efficient trial management. - April 30, 2024 - Anzu
Exploring Growth: API China 2024 Invites Global Visitors and Exhibitors to the Chinese Pharmaceutical Industry
API China, Asia’s premier pharmaceutical trade show, is gearing up for its 90th edition, scheduled to take place from May 15 to 17, 2024, at the prestigious National Exhibition and Convention Center in Shanghai. This year, API China will be collocated with PHARMCHINA and China International... - April 15, 2024 - RX
I Holland Unveils TSAR 2: Advancing Predictive Modelling in Tablet Compression
I Holland proudly announces the development of TSAR 2, an advanced predictive model developed through a collaborative partnership between academia and industry. Building upon the success of the Tabletting Science Anti-Stick Research (TSAR) project, I Holland continues its groundbreaking research... - April 12, 2024 - I Holland Ltd.
Boiron’s New Arnicare® Wellness Kits Offer Holistic Approach to Pain Management
Boiron, world leader in homeopathic medicines, introduces its new Arnicare Wellness Kits as convenient and comprehensive solutions for painsleep and stress relief. The kits are designed to provide individuals with daytime and nighttime options to manage pain with occasional sleeplessness and... - April 11, 2024 - Boiron
Huntington Study Group Launches Project AWARE 2.0 Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group
FuseBio Presents New Data at AACR: Targeting a Functionally-Selective IL-18 (F-18) to PD-1: A Next Generation Checkpoint Inhibitor with Enhanced Anti-Tumor Activity
FuseBio's unique attenuation mechanism renders IL-18, a functionally selective IL-18, resistant to IL-18BP and 1 million percent less active in circulation and yet still retain nearly full activity when targeted to PD-1+/IL-18R+ cells, the key functional immune cells in tumors. It is designed to retain full activity of PD-1 checkpoint blockade and simultaneously deliver a functionally selective IL-18 (F-18) to preserve and enhance the anti-tumor activity of immune cells. - April 09, 2024 - Fuse Biotherapeutics
PocketRN Brings No Cost "Virtual Nurse for Life" to Dementia Patients and Caregivers Under New 8-Year CMS GUIDE Model
The innovative model enables the expansion of personalized, expert nurse-led care to improve patients’ quality of life and alleviate burden on caregivers nationwide–all with $0 copays. - April 08, 2024 - PocketRN
Geoprise Releases Software to Support New SEC Climate Disclosure Rules
New release to substantially reduce the cost of compliance for most companies. - April 04, 2024 - Geoprise Technologies Corporation
Ngram Expands AI Dataset Offerings with Descriptive Question Answering for Healthcare
New open-source medchat-qa-descriptive dataset enables AI models to provide comprehensive answers to complex medical queries. - March 22, 2024 - ngram Inc.
Bench International Adds Industry Veteran Dr. Renee P. Tannenbaum to Executive Leadership Team
Tannebaum Brings Deep Industry Experience in Pharma and Biotech and Board Expertise to Meet Evolving Life Sciences Talent Demands - March 19, 2024 - Bench International
Sabina Ewing Awarded Bench and Deloitte Inaugural Life Sciences Tech Innovation Award
Award Recognizes Exceptional Contributions by Women in the Life Sciences Industry - March 15, 2024 - Bench International
The University of Iowa Selects TrialX to Build SAYSTOP Study App for a Leading Research Study to Investigate Antibiotics Resistance
To study a patient-centered approach to antibiotic discontinuation upon symptom resolution in patients with acute uncomplicated pyelonephritis. - March 13, 2024 - TrialX
Innovation in Healthcare: Medical Websites Vie for Coveted Best Medical Website WebAward
The Web Marketing Association is looking for the best medical websites in the world as part of their 28th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards is the standards-defining competition that sets benchmarks for 90 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites. - March 13, 2024 - Web Marketing Association
Safe Rx Welcomes Lon von Hurwitz as Market Access & Policy Director
Hire Coincides with Growth in Market Access for LPV® Dispensing - March 05, 2024 - Safe Rx
ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials
The ALS Therapy Development Insitute (ALS TDI) has announced the beta launch of the ALS Trial Navigator. This innovative set of tools is designed to guide people with ALS and caregivers through the process of finding and understanding ALS clinical trials – with the ultimate goal of personalizing the search process and helping users make informed decisions about participation in trials. - February 29, 2024 - ALS Therapy Development Institute
IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.
GENINVO, a Leading Provider of Life Science Product and Business Solutions Announced the Offering of Its On-Demand Service/Tool: ApoGI™
ApoGI™ is an integrated, one stop automation platform that leverages Artificial Intelligence and Machine Learning algorithms to focus on standards and metadata driven generation of artifacts. The Primary objective of this platform is to help SMEs (Subject matter experts) focus on curating... - February 15, 2024 - GenInvo, Inc.
Biomed Industries Inc. Seeks Collaboration for New Diabetes/Obesity Drug
Biomed Industries, Inc. (Biomed) announced today that it has developed a promising obesity drug, NA-921, which is poised for Phase 2/3 clinical trials. NA-921 is a small molecule drug available in oral formulation. The Company is in discussions with potential partners for collaboration on a Phase... - February 04, 2024 - Biomed Industries Inc.
Patient Experience and Satisfaction with Electronic Consent, Onboarding, and Diaries in Clinical Trials Report
New Market Research Shows Different Patient Preferences for Electronic Diaries - January 31, 2024 - Life Science Strategy Group, LLC
New Sustainable Lyophilization Technology Uses Supercritical CO2
The Thar group of companies have been using CO2 for extraction, purification, particle design and encapsulation for many years but recent developments point to a need for sustainable methods for drying APIs, intermediates, excipients and biologics at relatively low temperatures. 'Big Pharma' has depended on Thar for SFC tools in drug discovery but lyophilization will likely be used in manufacturing too. - January 28, 2024 - Thar Process, LLC
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics has announced the launch of its new Robenidine Test Reagents for the detection of robenidine residues. - January 26, 2024 - Creative Diagnostics
HearYou.org and Mark Cuban Cost Plus Drug Company: Pioneering Affordable Mental Health Care
Leaders in Mental Health and Pharmaceutical Pricing Forge Path for Accessible Treatment - January 25, 2024 - Wellness Together
David P. Summers, Ph.D., FACA Honored as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide
Dr. David P. Summers of Montgomery, Texas has been recognized as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of Biomedical Engineering/Pharmacology. About Dr. David P. Summers, PH.D,... - January 11, 2024 - Strathmore Worldwide
Bench International Enters Into Ground Breaking Strategic Alliance with Ashton Tweed
First of Its Kind Alliance Extends Mutual Service Offerings to Better Serve Clients - January 03, 2024 - Bench International
Empowering Data Privacy: GENINVO Offers Anonymization as a Service
GENINVO, a leading provider of life science product and business solutions announced the offering of its on-demand service Anonymization as a Service. GENINVO a trailblazer in data privacy solutions, is excited to introduce its ground-breaking offering, Anonymization as a Service. With data... - December 14, 2023 - GenInvo, Inc.
FF Biotherapeutics Announces Search for Angel Investment to Revolutionize Immunotherapy and Vaccine Development
FF Biotherapeutics, a pioneering biotech startup at the forefront of immunotherapy and vaccine development, today announced its active pursuit of Angel investment. This critical funding round aims to propel the development of its groundbreaking Synthetic Standardized Convalescent Plasma (SSCP) and... - November 29, 2023 - FF Biotherapeutics
SciCord Informatics Platform R3.0 Boron Release
SciCord is proud to announce a new release of its Cloud-based Laboratory Informatics Platform. - November 22, 2023 - SciCord
Huntington Study Group® Holds 30th Annual Meeting
The Huntington Study Group® (HSG®), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently held its 30th annual meeting, HSG 2023, November 2-4 in Phoenix, AZ. Hundreds of scientists, industry partners, HSG research... - November 21, 2023 - Huntington Study Group
Novugen Pharma (USA) LLC Launches ANDA Approved Midodrine 2.5mg, 5mg & 10mg
Novugen Pharma (USA) LLC has launched Midodrine 2.5mg, 5mg and 10mg in the U.S. upon the approval from ANDA by FDA. Novugen’s Midodrine will be manufactured in Malaysia by Novugen Pharma Sdn. Bhd. Midodrine is indicated for the treatment of symptomatic orthostatic hypotension, a condition defined as a sudden drop in blood pressure upon standing from a sitting or supine position. - November 07, 2023 - Novugen